Developing Tetravalent siRNAs for Efficient and Safe Silencing of Retinal Genes

1:00 pm - Friday 29th January 2027

  • Exploring chemistries for retinal genes silencing
  • Understanding target cells for disease alterations
  • Establishing pre-clinical efficacies and safety in non-human primates

New Data

Speakers:

Co-Founder and CSO
Trinetra Therapeutics